SEARCH

SEARCH BY CITATION

References

  • Åberg LE, Backman M, Kirveskari E, Santavuori P. (2000) Epilepsy and antiepileptic drug therapy in juvenile neuronal ceroid lipofuscinosis. Epilepsia41:12961302.
  • Alacqua M, Trifirò G, Spina E, Moretti S, Tari DU, Bramanti P, Caputi AP, Arcoraci V. (2009) Newer and older antiepileptic drug use in southern Italy: a population-based study during the years 2003–2005. Epilepsy Res85:107113.
  • Anders M. (1966) Rapid micromethod for gas chromatographic determination of blood barbiturates. Anal Chem38:19451947.
  • Bacon CJ, Hierons AM, Mucklow JC, Webb JK, Rawlins MD, Weightman D. (1981) Placebo-controlled study of phenobarbitone and phenytoin in the prophylaxis of febrile convulsions. Lancet2:600604.
  • Barnes ER, Thompson DF. (1993) Antenatal phenobarbital to prevent or minimize intraventricular hemorrhage in the low-birthweight neonate. Ann Pharmacother27:4952.
  • Bialer M. (2012) How did phenobarbital’s chemical structure affect the development of subsequent antiepileptic drugs (AEDs)?Epilepsia53(Suppl. 8):311.
  • Bird CAK, Griffin BP, Miklasewska MJ, Galbraith AW. (1966) Tegretol (carbamazepine): a controlled trial of a new anticonvulsant. Br J Psychiatry112:737742.
  • BNF. (2012a) Carbamazepine (tegretol) [online]. BMJ Group and Pharmaceutical Press, London. Available at: http://www.medicinescomplete.com/mc/bnf/current/3577.htm?q=carbamazepine&t=search&ss=text&p=1#_hit [Accessed August 26, 2012].
  • BNF. (2012b) Lamotrigine (lamictal) [online]. BMJ Group and Pharmaceutical Press, London. Available at: http://www.medicinescomplete.com/mc/bnf/current/9833.htm#_9833 [Accessed August 26, 2012].
  • BNF. (2012c) Phenobarbital [online]. BMJ Group and Pharmaceutical Press, London. Available at: http://www.medicinescomplete.com/mc/bnf/current/search.htm?q=phenobarbital [Accessed August 26, 2012].
  • BNF. (2012d) Retigabine (trobalt) [online]. BMJ Group and Pharmaceutical Press, London. Available at: http://www.medicinescomplete.com/mc/bnf/current/215509.htm#_215509 [Accessed August 26, 2012].
  • BNF. (2012e) Valproate (epilim) [online]. BMJ Group and Pharmaceutical Press, London. Available at: http://www.medicinescomplete.com/mc/bnf/current/3601.htm#_3601 [Accessed August 26, 2012].
  • British Pharmacopoeia. (1914) British Pharmacopoeia Commission. Constable & co. ltd, London.
  • Brook C. (1922) Report of the medical officer. The National Society of Epilepsy: 30th Annual Report: 19.
  • Brook C. (1923) Report of the medical officer. The National Society of Epilepsy: 30th Annual Report: 28.
  • Buchthal F, Svensmark O, Simonsen H. (1968) Relation of EEG and seizures to phenobarbital in serum. Arch Neurol19:567572.
  • Bush M. (1961) Sedatives and hypnotics: absorption fate and excretion. In Root WS, Hoffmann FG (Eds) Physiological pharmacology. Vol. 561. Academic Press, New York, pp. 185218.
  • Butler TC. (1952) Quantitative studies of the metabolic fate of mephobarbital (N-methylphenobarbital). J Pharmacol Exp Ther106:235245.
  • Butler TC, Mahaffee C, Waddell WJ. (1954) Phenobarbital: studies of elimination, accumulation, tolerance, and dosage schedules. J Pharmacol Exp Ther111:425435.
  • Camfield PR, Camfield CS, Shapiro SH, Cummings C. (1980) The first febrile seizure – antipyretic instruction plus either phenobarbital or placebo to prevent recurrence. J Pediatr97:1621.
  • Cereghino JJ, Brock JT, Van Meter JC, Penry JK, Smith LD, White BG. (1974) Carbamazepine for epilepsy. A controlled prospective evaluation. Neurology24:401410.
  • Chanarin I, Laidlaw J, Loughridge LW, Mollin DL. (1960) Megaloblastic anaemia due to phenobarbitone. BMJ1:10991102.
  • Chen YJ, Kang WM, So WC. (1996) Comparison of antiepileptic drugs on cognitive function in newly diagnosed epileptic children: a psychometric and neurophysiological study. Epilepsia37:8186.
  • Controlled Substances Act. (1970a) 21 USC § 801 – Congressional findings and declarations: controlled substances [online]. USA. Available at: http://www.fda.gov/regulatoryinformation/legislation/ucm148726.htm [Accessed September 4, 2012].
  • Controlled Substances Act. (1970b) 21 USC § 801 – Congressional findings and declarations: controlled substances, part D: offenses and penalties [online]. USA. Available at: http://www.fda.gov/regulatoryinformation/legislation/ucm148726.htm#cntlsbd [Accessed September 4, 2012].
  • Crawford TO, Mitchell WG, Fishman IS, Snodgrass SR. (1988) Very-high-dose phenobarbital for refractory status epilepticus in children. Neurology38:10351040.
  • Crowther CA, Henderson-Smart DJ. (2003) Phenobarbital prior to preterm birth for preventing neonatal periventricular haemorrhage. Cochrane Database Syst Rev3:CD000164.
  • Crowther CA, Crosby DD, Henderson-Smart DJ. (2010) Phenobarbital prior to preterm birth for preventing neonatal periventricular haemorrhage. Cochrane Database Syst Rev1:CD000164.
  • Czapinski P, Terczynski A, Czapinska E. (1997) Randomised 36-month comparative study of valproic acid, phenytoin, phenobarbital and carbamazepine efficacy in patients with newly diagnosed epilepsy with partial complex seizures. 22nd International Epilepsy Congress 1997 Dublin, Ireland. Epilepsia, 38(Suppl. 3):1288.
  • De Silva M, Macardle B, Mcgowan M, Hughes E, Stewart J, Neville BG, Johnson AL, Reynolds EH. (1996) Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet347:709713.
  • De Vries SI. (1965) Haematological aspects during treatment with anticonvulsant drugs. Epilepsia6:115.
  • Dörks M, Langner I, Timmer A, Garbe E. (2012) Treatment of paediatric epilepsy in Germany: antiepileptic drug utilisation in children and adolescents with a focus on new antiepileptic drugs. Epilepsy Res July 11 [Epub ahead of print].
  • Faerø O, Kastrup KW, Lykkegaard Nielsen E, Melchior JC, Thorn I. (1972) Successful prophylaxis of febrile convulsions with phenobarbital. Epilepsia13:279285.
  • Feely M, O’Callagan M, Duggan B, Callaghan N. (1980) Phenobarbitone in previously untreated epilepsy. J Neurol Neurosurg Psychiatry43:365368.
  • Feksi AT, Kaamugisha J, Sander JWAS, Gatiti S, Shorvon SD. (1991) Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICEBERG (International Community-Based Epilepsy Research Group). Lancet337:406409.
  • Gathwala G, Marwah A, Gahlaut V, Marwah P. (2011) Effect of high-dose phenobarbital on oxidative stress in perinatal asphyxia: an open label randomized controlled trial. Indian Pediatr48:613617.
  • Golla F. (1921) Luminal contrasted with bromide in epilepsy. BMJ27:320321.
  • Grinker J. (1920) Experiences with luminal in epilepsy. JAMA75:588592.
  • Grinker J. (1922) Further experiences with phenobarbital (luminal) in epilepsy. JAMA79:788793.
  • Gruber CM Jr, Brocket JT, Dyken M. (1962) Comparison of the effectiveness of phenobarital, mephobarbital, primidone, diphenylhydantoin, ethotoin, metharbital, and methylphenylethylhydantoin in motor seizures. Clin Pharmacol Ther3:2328.
  • Hall RT, Hall FK, Daily DK. (1998) High-dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: a randomized, prospective study with three-year follow-up. J Pediatr132:345348.
  • Hamer H, Dodel R, Strzelczyk A, Balzer-Geldsetzer M, Reese JP, Schöffski O, Graf W, Schwab S, Knake S, Oertel W, Rosenow F, Kostev K. (2012) Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany – a nationwide population-based study in children and adults. J Neurol Apr 28 [Epub ahead of print].
  • Hauptmann A. (1912) Luminal bei epilepsie. Munch Med Wochenschr59:19071909.
  • Hauptmann A. (1919) Erfahrungen aus der behandlung der epilepsie mit luminal. Munch Med Wochenschr46:13191321.
  • Haward F. (1924) Report of the medical officer. The National Society of Epilepsy.
  • Haward F. (1926) Report of the medical officer. The National Society of Epilepsy.
  • Haward F. (1928) Report of the medical officer. The National Society of Epilepsy.
  • Hawkings CF, Meynell MJ. (1958) Macrocytosis and macrocytic anaemia caused by anticonvulsant drugs. Q J Med27:4563.
  • Heller AJ, Chesterman P, Elwes RD, Crawford P, Chadwick D, Johnson AI, Reynolds EH. (1995) Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry58:4450.
  • Hsieh IP, Huang CY. (2009) Antiepileptic drug utilization in Taiwan: analysis of prescription using national health insurance database. Epilepsy Res84:2127.
  • Jilek-Aall l, Rwiza HT. (1992) Prognosis of epilepsy in a rural African community: a 30-year follow-up of 164 patients in an outpatient clinic in rural Tanzania. Epilepsia33:645650.
  • Johannessen Landmark C, Fossmark H, Larsson PG, Rytter E, Johannessen SI. (2011) Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population. Epilepsy Res95:5159.
  • Johnson W. (1922) A note on luminal. Lancet200:275276.
  • Kalra V, Gulati S, Pandey RM, Menon S. (2001) West syndrome and other infantile epileptic encephalopathies – Iindian hospital experience. Brain Dev23:593602.
  • Kekulé A. (1865) Sur la constitution des substances aromatiques. Bull Soc Chim Paris3:98110.
  • Knudsen FU, Vestermark S. (1978) Prophylactic diazepam or phenobarbitone in febrile convulsions: a prospective, controlled study. Arch Dis Child53:660663.
  • Kruse R. (1968) Osteopathies in antiepileptic long-term therapy (preliminary report). Monatsschr Kinderheilkd116:378381.
  • Kwan P, Brodie MJ. (2004) Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia45:11411149.
  • Kwong KI, Tsui KW, Wu SP, Yung A, Yau E, Eva F, Ma CK, Cherk S, Liu KT, Cheng WW, Yau MM. (2012) Utilization of antiepileptic drugs in Hong Kong children. Pediatr Neurol46:281286.
  • Laing R, Waning B, Gray A, Ford N, ‘t Hoen E. (2003) 25 years of the WHO essential medicines lists: progress and challenges. Lancet361:17231729.
  • Lee WK, Liu KT, Young BWY. (2006) Very-high-dose phenobarbital for childhood refractory status epilepticus. Pediatr Neurol34:6365.
  • Lennox WG. (1938) The literature on epilepsy in 1936. Epilepsia 2nd Series; 1:128164.
    Direct Link:
  • Lennox WG. (1939) Progress in the study of epilepsy in America in 1937. Epilepsia 2nd series; 1:196208.
  • Lennox WG. (1940) Study of epilepsy in America in 1938. Epilepsia 2nd series; 1:279291.
  • Lennox WG. (1942) Brain injury, drugs and environment as causes of mental decay in epilepsy. Am J Psychiatry99:174180.
  • Lennox WG, Lennox M. (1960) Epilepsy and related disorders. Little Brown, Boston, MA.
  • Lerman-Sagie T, Lerman P. (1999) Phenobarbital still has a role in epilepsy treatment. J Child Neurol14:820821.
  • Livingstone S. (1966) Drug therapy for epilepsy. Charles C Thomas, Springfield.
  • López-Muñoz F, Ucha-Udabe R, Alamo C. (2005) The history of barbiturates a century after their clinical introduction. Neuropsychiatr Dis Treat1:329343.
  • Löscher W, Rogawski M. (2012) How theories evolved concerning the mechanism of action of barbiturates. Epilepsia53(Suppl. 8):1225.
  • Malerba A, Ciampa C, De Fazio S, Fattore C, Frassine B, La Neve A, Pellacani S, Specchio LM, Tiberti A, Tinuper P, Perucca E. (2010) Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy. Epilepsy Res91:273282.
  • Mamelle N, Mamelle JC, Plasse JC, Revol M, Gilly R. (1984) Prevention of recurrent febrile convulsions – a randomized therapeutic assay: sodium valproate, phenobarbital and placebo. Neuropediatrics15:3742.
  • Mani KS, Rangan G, Srinivas HV, Srindharan VS, Subbakrishna DK. (2001) Epilepsy control with phenobarbital or phenytoin in rural south India: the Yelandur Study. Lancet357:13161320.
  • Masuko AH, Castro AA, Santos GR, Atallah AN, Do Prado LB, De Carvalho LB, Do Prado GF. (2003) Intermittent diazepam and continuous phenobarbital to treat ecurrence of febrile seizures: a systematic review with meta-analysis. Arq Neuropsiquiatr61:897901.
  • Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, Williamson PD, Treiman DM, Mcnamara JO, Mccutchen CB, Homan RW, Crill WE, Lubozynski MF, Rosenthal NP, Mayersdorf A. (1985) Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic–clonic seizures. N Engl J Med313:145151.
  • Mcgreachy TE, Bloomer WE. (1953) The phenobarbital sensitivity syndrome. Am J Med14:600604.
  • Mckinlay I, Newton R. (1989) Intention to treat febrile convulsions with rectal diazepam, valproate or phenobarbitone. Dev Med Child Neurol31:617625.
  • Meador KJ, Loring DW, Moore EE, Thompson WO, Nichols ME, Oberzan RE, Durkin MW, Gallagher BB, King DW. (1995) Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology45:14941499.
  • Millichap J. (1965) Aticonvulsant drugs: clinical and electrocencephalographic indications, efficacy and toxicity. Postgrad Med37:2234.
  • Mitchell WG, Chavez JM. (1987) Carbamazepine versus phenobarbital for partial onset seizures in children. Epilepsia28:5660.
  • Morselli PA, Rizzo M, Garattini S. (1971) Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients. Ann N Y Acad Sci6:88107.
  • MSH. (2010) Phenobarbital-international drug price indicator guide [online]. Management Science for Health, Cambridge, MA. Available at: http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=phe100t&s_year=2010&year=2010&str=100%20mg&desc=phenobarbital&pack=new&frm=tab-cap&rte=po&class_code2=05%2e&supplement=&class_name=%2805%2e%29anticonvulsants%2fantiepileptics%3cbr%3e [Accessed August 24, 2012].
  • Musicco M, Beghi E, Solari A, Viani F. (1997) Treatment of first tonic–clonic seizure does not improve the prognosis of epilepsy. FIRst Seizure Trial Group (FIRST Group). Neurology49:991998.
  • Muskens L. (1924) Epilepsie: vergelijkende pathogenese, verschijnselen, behandeling. Van Rossen, Amsterdam.
  • Nimaga K, Desplats D, Doumbo O, Farnarier G. (2002) Treatment with phenobarbital and monitoring of epileptic patients in rural Mali. Bull World Health Organ80:532537.
  • Painter MJ, Scher MS, Stein AD, Armatti S, Wang Z, Gardiner JC, Paneth N, Minnigh B, Alvin J. (1999) Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med341:485489.
  • Pal DK, Das T, Chaudhury G, Johnson AL, Neville BG. (1998) Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet351:1923.
  • Patterson H, Damon LG, Levi P. (1926) A comparative study of various methods of the administration of luminal in epilepsy. J Nerv Ment Dis63:275.
  • Placencia M, Sander JW, Shorvon SD, Roman M, Alarcon F, Bimos C, Cascante S. (1993) Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment. Epilepsy Res14:237244.
  • Plum P. (1937) Clinical and experimental investigation in agranulocytosis. H. K. Lewis Co, London.
  • Rantala H, Tarkka R, Uhari M. (1997) A meta-analytic review of the preventive treatment of recurrences of febrile seizures. J Pediatr131:922925.
  • Reynolds EH. (1975) Chronic antiepileptic toxicity: a review. Epilepsia16:319352.
  • Rochat P, Hallas J, Gaist D, Friis ML. (2001) Antiepileptic drug utilization: a Danish prescription database analysis. Acta Neurol Scand104:611.
  • RPS. (2010) A-Z list of human medicines [online]. Royal Pharmacist Society, London. Available at: http://www.rpharms.com/support-pdfs/az-list-of-human-medicines-July-2010.pdf [Accessed August 16, 2012].
  • Ruth V, Virkola K, Paetau R, Raivio KO. (1988) Early high-dose phenobarbital treatment for prevention of hypoxic-ischemic brain damage in very low birth weight infants. J Pediatr112:8186.
  • Salonga AM, Lukban MB, Ortiz MH, Balatero-Terencio B, Lagman AM. (2001) West syndrome: the Philippine experience. Brain Dev23:616623.
  • Savica R, Beghi E, Mazzaglia G, Innocenti F, Brignoli O, Cricelli C, Caputi AP, Musolino R, Spina E, Trifirò G. (2007) Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000–2005. Eur J Neurol14:13171321.
  • Schmidt D, Einicke I, Haenel F. (1986) The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine. Arch Neurol43:263265.
  • Sexton DL, Pike GM, Nielson A. (1941) Exfoliative dermatitis and death due to Phenobarbital. JAMA1116:700701.
  • Shaner DM, Mccurdy SA, Herring MO, Gabor AJ. (1988) Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology38:202207.
  • Shorvon SD. (2009) Drug treatment of epilepsy in the century of the ILAE: the first 50 years 1909–1959. Epilepsia50(Suppl. 3):125.
  • Shorvon SD. (2010) The antiepileptic drugs – phenobarbital. In Shorvon SD (Ed.) Handbook of epilepsy treatment. 3rd ed. Wiley-Blackwell, Chichester, pp. 210218.
  • Shorvon SD, Sander JWAS. (1996) The treatment of epilepsy at the National Hospital Queen Square, 1857–1939: a mirror of the first phase of the modern history of medical and surgical therapy. In Shorvon SD, Dreifuss F, Fish D, Thomas D (Eds) The treatment of epilepsy. Blackwell Science, Oxford, pp. xviixliv.
  • Shorvon SD, Weiss G, Avanzini G, Engel J, Meinardi H, Moshe S, Reynolds E, Wolf P. (2009) The International League Against Epilepsy 1909–2009: A centenary history. Oxford, Wiley Blackwell.
  • Singh D, Kumar P, Majumdar S, Narang A. (2004) Effect of phenobarbital on free radicals in neonates with hypoxic ischemic encephalopathy – a randomized controlled trial. J Perinat Med32:278281.
  • Singh D, Kumar P, Narang A. (2005) A randomized controlled trial of phenobarbital in neonates with hypoxic ischemic encephalopathy. J Matern Fetal Neonatal Med18:391395.
  • Sneddon IB, Lishman AWD. (1952) Severe and fatal phenobarbitone eruprtions. BMJ1:12761278.
  • Sykes RM. (2002) Epilepsy in children in Benin City, Nigeria. Ann Trop Paediatr22:287296.
  • Taylor S, Tudur Smith C, Williamson PR, Marson AG. (2001) Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic–clonic seizures. Cochrane Database Syst Rev4:CD002217.
  • The Home Office. (2009) Class A, B and C drugs [online]. The Home Office via The National Archives website, London. Available at: http://webarchive.nationalarchives.gov.uk/+/http://www.homeoffice.gov.uk/drugs/drugs-law/class-a-b-c/ [Accessed August 16, 2012].
  • The Misuse of Drugs Act 1971 (Modification). (1984) London. Available at: http://www.legislation.gov.uk/uksi/1984/859/contents/made [Accessed September 4, 2012].
  • The Misuse of Drugs Regulations. (2001). London. Available at: http://www.legislation.gov.uk/uksi/2001/3998/made [Accessed September 4, 2012].
  • Thilothammal N, Kannan S, Krishnamurthy PV, Kamala KG, Ahamed S, Banu K. (1993) Role of phenobarbitone in preventing recurrence of febrile convulsions. Indian Pediatr30:637642.
  • Thilothammal N, Banu K, Ratnam RS. (1996) Comparison of phenobarbitone, phenytoin with sodium valproate: randomized, double-blind study. Indian Pediatr33:549555.
  • Tholl DA, Miller TQ, Henderson WG, Myers TF. (1994) Meta-analysis of phenobarbital usage for prevention of intraventricular hemorrhage in premature infants: factors related to variation in outcome. Clin Trials Metaanal29:177190.
  • Tiamkao S, Mayurasakorn N, Suko P, Jitpimolmard S, Arunpongpaisal S, Phuttharak W, Auevitchayapat N, Vannaprasaht S, Phunikhom K, Chaiyakum A, Saengsuwan J. (2007) Very high dose phenobarbital for refractory status epilepticus. J Med Assoc Thai90:25972600.
  • Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, Mamdani MB. (1998) A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med339:792798.
  • Tsiropoulos I, Gichangi A, Andersen M, Bjerrum L, Gaist D, Hallas J. (2006) Trends in utilization of antiepileptic drugs in Denmark. Acta Neurol Scand113:405411.
  • Tudur Smith C, Marson AG, Williamson PR. (2003) Carbamazepine versus phenobarbitone monotherapy for epilepsy. Cochrane Database Syst Rev1:CD001904.
  • UN. (1971) Convention on psychotrpic substances, 1971. The United Nations Conference for the adoption of a protocol on psychotropic substances, Vienna.
  • Van Creveld S. (1958) New aspects of hemorrhagic disease of the newborn. Arch Fr Pediatr15:721735.
  • Van De Vrie-Hoekstra NW, De Vries TW, Van Den Berg PB, Brouwer OF, De Jong-Van Den Berg LTW. (2008) Antiepileptic drug utilization in children from 1997–2005 – a study from the Netherlands. Eur J Clin Pharmacol64:10131020.
  • Van Der Korst JK, Colenbrander H, Cats A. (1966) Phenobarbital and the shoulder-hand syndrome. Ann Rheum Dis25:553555.
  • Vargas-Origel A, Espinosa-Garcia JO, Muniz-Quezada E, Vargas-Nieto MA, Aguilar-Garcia G. (2004) Prevention of hypoxic-ischemic encephalopathy with high-dose, early phenobarbital therapy. Gac Med Mex140:147153.
  • von Baeyer A. (1864) Untersuchungen über die harnsäuregruppe. Der Chemie Und Pharmacie131:291.
  • Walton J. (1977) Brain’s diseases of the nervous system. Oxford University Press, Oxford.
  • Wang WZ, Wu JZ, Ma GY, Dai XY, Yang B, Wang TP, Yuan CL, Hong Z, Bell GS, Prilipko l, De Boer HM, Sander JW. (2006) Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural China. Lancet Neurol5:4652.
  • Wapner I, Thurston DL, Holowah J. (1962) Phenobarbital. Its effect on learning in epileptic children. JAMA182:937.
  • Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. (2007) Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord9:353412.
  • Whitelaw A, Odd D. (2007) Postnatal phenobarbital for the prevention of intraventricular hemorrhage in preterm infants. Cochrane Database Syst Rev4:CD001691.
  • WHO. (1977) The selection of essential drugs: a report of a WHO expert committee. WHO Technical Report Series, 615. World Health Organization, Geneva.
  • WHO. (1979) The use of essential drugs: second report of a who expert committee. WHO Technical Report Series, 641. World Health organization, Geneva.
  • WHO. (1987) The use of essential drugs. Third report of the who expert committee. WHO Technical Report Series, 770 . World Health Organization, Geneva.
  • WHO. (2001) How to develop and implement a national drug policy, updates and replaces guidelines for developing national drug policies, 1988. World Health Organization, Geneva.
  • WHO. (2005) Antiepileptic drugs. In Atlas: epilepsy care in the world. World Health Organization, Geneva.
  • WHO. (2007) The selection and use of essential drugs: report of WHO expert committee: 2007 (including the 15th model list of essential drugs). WHO Technical Report Series, 946. World Health Organization, Geneva.
  • WHO. (2008) Phenobarbital [online]. Available at: http://archives.who.int/emlib/medicinedisplay6199.html?language=en&medidname=244%40phenobarbital [Accessed July 31, 2012].
  • WHO. (2010a) Standard antiepileptic drugs (phenobarbital, phenytoin, carbamazepine, valproic acid) for management of convulsive epilepsy in adults and children [online]. World Health Organization, Geneva. Available at: http://www.who.int/mental_health/mhgap/evidence/epilepsy/mh_evidence_prof_epilpesy_q7_aed_2010_en.pdf.
  • WHO. (2010b) Medicines: access to controlled medicines (narcotic and psychotropic substances) [online]. World Health Organization, Geneva. Available at: http://www.who.int/mediacentre/factsheets/fs336/en/ [Accessed August 17, 2012].
  • Wilmshurst JM, Van Der Walt JS, Ackermann S, Karlsson MO, Blockman M. (2010) Rescue therapy with high-dose oral phenobarbitone loading for refractory status epilepticus. J Paediatr Child Health46:1722.
  • Wilson SA. (1940) Neurology. Edward Arnold, London.
  • Wolf SM, Carr A, Davis DC, Davidson S, Dale EP, Forsythe A, Goldenberg ED, Hanson R, Lulejian GA, Nelson MA, Treitman P, Weinstein A. (1977) The value of phenobarbital in the child who has had a single febrile seizure: a controlled prospective study. Pediatrics59:378385.
  • Woodbury DM, Penry JK, Schmidt RP. (1972) Antiepileptic drugs. Raven Press, New York.
  • World Health Assembly. (1975) Resolution WHA28.66. World Health Organization, Geneva.